Clinical trial Recruiting at 1 site Interventional Ages 22 to 65

Investigation of a brain-computer interface for tetraplegia rehabilitation

Official title: Investigation on the Bidirectional Cortical Neuroprosthetic System

Run by Johns Hopkins University · NCT03161067 · Data updated 2026-11-12

This study is testing a new brain-computer system to see if it can help people with tetraplegia regain movement and feel sensations again.

More Tetraplegia trials

Quick facts

Study typeInterventional
Ages22 Years to 65 Years
SexAll
Enrollment5 (estimated)
SponsorJohns Hopkins University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedAugust 1, 2017
Main results expectedDecember 31, 2028
Study endsDecember 31, 2030
Registry record updatedAugust 21, 2026
Trial IDNCT03161067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with C4-C6 tetraplegia who have had their injury for more than one year and meet specific medical and psychological criteria.

Probably not a fit

Patients with neurodegenerative diseases or active cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early feasibility study evaluates the safety and efficacy of the Bidirectional Cortical Neuroprosthetic System (BiCNS), which utilizes advanced neuroelectrode technology to facilitate communication between the brain and external devices. Participants with tetraplegia will have electrode arrays implanted in their brain to record neural signals and stimulate sensory feedback. The study aims to assess how well this system can help restore motor function and sensory perception in individuals with severe spinal cord injuries. The approach involves a combination of neural recording and intracortical microstimulation to create a bidirectional interface for rehabilitation.

Why it matters

Potential benefit: If successful, this study could significantly enhance rehabilitation outcomes for patients with tetraplegia by restoring motor control and sensory feedback.

How similar studies have gone: Other studies utilizing brain-computer interfaces have shown promising results, indicating potential for success with this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants must meet all inclusion criteria, verified by medical evaluation, psychological evaluation, and review of medical history. Inclusion criteria include:

* Participants with C4-C6 tetraplegia from any etiology except neurodegenerative disease (e.g. amyotrophic lateral sclerosis) or active cancer.
* Complete or incomplete spinal cord injury classified by the American Spinal Injury Association (ASIA) as A or B or C if fewer than three muscle groups in the leg and foot (as identified in the ASIA Impairment Scale) can be contracted
* Injury more than one year prior to enrollment
* Participant has a life expectancy of greater than 5 years
* Meeting surgical safety criteria, including surgical clearance by the participant's primary healthcare provider, study physicians, and any necessary consultants
* Willingness and ability to provide informed consent
* Screened by rehabilitation psychologist with a result showing that the participant has a stable psychosocial support system with caregiver capable of monitoring participant throughout the study
* Ability and willingness to travel to up to fifty miles to study location up to three days per week for the duration of the study
* Ability to understand and comply with study session instructions
* Pain well controlled without narcotic medications
* No other neurological, orthopedic conditions beyond the spinal cord injury
* Participant consents to the study and still wishes to participate at the time of the study

Exclusion Criteria:

All interested participants will be reviewed for the presence of exclusion criteria by medical evaluation, review of medical history, self (or assistant) report and evaluation by a psychologist. Presence of any of the following criteria will exclude participants from eligibility to participate. In addition, the medical team has the right to withdraw the participant at any time if any of the exclusion criteria emerge and participants can withdraw at any time for any reason. Withdrawal details are outlined below exclusion criteria. Exclusion criteria include:

* Neurological conditions: Impaired receptive and/or expressive verbal communication skills
* Presence of memory impairment on the Rey Auditory Verbal Learning Test
* Intellectual impairment: score of 26 or less on the Mini-Mental State Examination or history of Intelligence Quotient \< 80
* Chronic psychiatric illness, including psychosis and treatment-resistant major depression, as indicated by a diagnosis of Axis I or Axis II on the Symptom Checklist-90-Revised Test
* Ventilator dependent
* Implanted devices such as: pacemakers, cardiac defibrillators, spinal cord or vagal nerve stimulators, deep brain stimulators, cochlear implants or any other implantable device incompatible with MRI.
* History of drug or alcohol dependence in past 24 months
* Cerebral lesions affecting frontal and parietal lobes
* Medical conditions contraindicating surgery of a chronically implanted device (e.g. osteomyelitis, diabetes, hepatitis, any autoimmune disease/disorder, epilepsy, skin disorders causing excessive skin sloughing or poor wound healing, blood or cardiac disorder requiring chronic anti-coagulation)
* Other chronic, unstable medical conditions that could make control unsuitable (such as tremor or spasticity)
* Presence of pre-surgical findings in anatomical, functional, and/or vascular neuroimaging that makes achieving implant locations within desired risk levels too challenging (to be decided by neurological and neurosurgical team)
* Prior cranioplasty
* Inability to undergo MRI or anticipated need for an MRI during the study period
* Participants with active infections or unexplained fever
* Participants with other morbid conditions making the implantation of the recording elements unsafe; not limited to: significant pulmonary, cardiovascular, or renal impairments making the surgical procedure unsafe
* Pregnancy (confirmation through blood test)
* Nursing an infant, planning to become pregnant, or not using adequate birth control
* Corrected vision no worse than 20/30
* HIV or AIDS infection
* Existing scalp lesions or skin breakdown
* Chronic oral or intravenous use of steroids or immunosuppressive therapy
* Active cancer within the past year or requires chemotherapy
* Uncontrolled autonomic dysreflexia within the past 3 months
* An implanted ventricular shunt
* Suicidal ideation within the past 12 months
* Medications that affect neuroplasticity: neuroleptics, Benzodiazepines (BDZ), Tricyclic Antidepressants (TCA).

Where it's running

  • Department of Neurology
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Nathan E Crone, MD — Johns Hopkins University
  • Study coordinator: Nathan E Crone, MD
  • Email: ncrone@jhmi.edu
  • Phone: 4109559441

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.